Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of ...

At close: November 8 at 4:00 PM EST ...

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic ...

Dyne Therapeutics Inc.-2.70% $2.94B ...

Relay Therapeutics Inc ( (RLAY)) has released its Q3 earnings. Here is a breakdown of the information Relay Therapeutics Inc presented to its investors. Relay Therapeutics Inc., a clinical-stage ...

Analyst Silvan Tuerkcan of JMP Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report), retaining the price target of $86.00. Silvan Tuerkcan has given his Buy ...

The non-profit Digital Therapeutics Alliance (DTA) – working with clinical trials specialist Curebase – has drawn up the document to help encourage the development of DTx products and get them ...